According to the report "In-Vitro Diagnostics Market", published by Market Data Forecast, the global market is projected to reach USD 78.07 Billion by 2020, at a CAGR of 5.6% from 2015 to 2020.
Global In-Vitro diagnostics market has been estimated at USD 59.45 billion in 2015 and is expected to reach 78.07 billion at a Compound Annual Growth Rate (CAGR) of 5.6%. In-Vitro diagnostics can be described as tests that can help in detecting diseases, conditions or infections. Some of these tests are performed in laboratory or healthcare settings while other tests are for consumers to use at home.
In-vitro diagnostics (IVD) are designed to observe diseases, infections, and conditions and conjointly monitor an individual's state of health and therapeutic procedures by examining specimens derived from the individual’s body. In vitro diagnostics play a vital role in risk assessment and illness monitoring. Robust advancements have been achieved recently, notably within the field of clinical immunology.
Global companion diagnostics spectrum comprising synergic development of drugs as well as diagnostics to facilitate superlative patient benefits and affordable pricing steer growth in global companion diagnostics partnering space. Growing burden of chronic maladies as well as rising menace of uncontrolled infections continue to remain potential challenges in healthcare spectrum, thus encouraging significant companion diagnostics developments and alliances. Market Research Hub (MRH) in its ... Read more
Diagnostic deals associated with Alzheimer’s disease and contagious disease, namely Zika virus have signified the importance of diagnostic partnering in oncology. In 2017, genetic technology became the kingpin for the oncology diagnostic related acquisition. In a bid to strengthen its health care offerings through expansion, a deal partly funded by Japan’s public/private Innovation Network Corporation witnessed Konica Minolta Inc. agreeing to pay USD 800 million in cash along with up to USD ... Read more
